Remove 2027 Remove Compounding Remove Sterile Compounds
article thumbnail

Piramal Pharma Solutions announces $80M expansion at Lexington Facility

Express Pharma

The site specialises in sterile compounding, liquid filling, and lyophilisation for sterile injectable drug products. Upon completion of the expansion, scheduled for Q1 2027, this will increase to over 240 annual batches. Current capacity at the Lexington site stands at 104 product batches per year.